| OA17.03 | The value of outside engagement-civil society led engagement in PopART | Oral Abstract Session | Community engagement in prevention research |
| OA17.02 | A synergistic model of engagement: the ECHO Global Community Advisory Group and HC-HIV Advocacy Working Group | Oral Abstract Session | Community engagement in prevention research |
| OA17.01 | Eliciting participant feedback in focus group discussions to strengthen the implementation of a HIV prevention study | Oral Abstract Session | Community engagement in prevention research |
| OA16.05 | A randomized, double blind, placebo-controlled, phase 1 safety and pharmacokinetic study of dapivirine gel (0.05%) administered rectally to HIV-1 seronegative adults (MTN-026) | Oral Abstract Session | Pharmacology/PK and PD studies |
| OA16.04 | Phase 1 safety and pharmacokinetic study of candidate rectal microbicide PC-1005 rectal gel (MIV-150/zinc acetate /carrageenan) in HIV-1 seronegative adults (MTN-037) | Oral Abstract Session | Delivery technologies: novel approaches, formulation and multi-purpose |
| OA16.03 | Comparing Applicator vs. “As Lubricant” Delivery of Rectal Dapivirine Gel (MTN-033) | Oral Abstract Session | COVID research: Applying lessons from HIV prevention to SARS CoV-2 |
| OA16.02 | For MSM attending sexual health clinics in England, rates of new HIV infections decreased and rates of new rectal GC diagnosis increased between 2010-2018 | Oral Abstract Session | Epidemiology of HIV |
| OA16.01 | Trends in incidence of bacterial sexually transmitted infections among gay and bisexual men using PrEP in Australia | Oral Abstract Session | Implementation science, including structural interventions, PrEP & VMMC |
| OA15.05LB | Cross-reactivity between HIV-1 bnAbs and parasite glycans | Oral Abstract Session | Novel vaccine and other prevention approaches |
| OA15.04 | Structural basis of neutralizing antibodies targeting the CD4-binding site and fusion peptide elicited by immunization with heterologous HIV-1 Env in NHP | Oral Abstract Session | Novel vaccine and other prevention approaches |